A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists

Novo Nordisk A/S1,500 enrolled

Overview

This is a survey-based study with the objective to understand the awareness, perceptions and potential clinical management patterns among Chinese cardiologists and nephrologists towards the role of systemic inflammation in patients with ASCVD and CKD in real-world clinical setting.

Study Type

OBSERVATIONAL

Enrollment

1,500

Conditions

Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)

Interventions

No treatment givenOTHER

Online self-completion survey

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Work in cardiology, internal medicine, or nephrology department * Specialize in one of the following: coronary interventional cardiology, HF, general cardiology, preventive cardiology, cardiac rehabilitation or nephrology * Practice at consultant level for 3+ years after standardized training for resident physicians or 3+ years' working experience as a specialist * Manage at least 20 adult patients with ASCVD and CKD (not dialysis-only) every month Exclusion Criteria: * Unwilling to provide informed consent * Insufficient number of patients with ASCVD and CKD * Do not fulfil inclusion criteria.

Locations (1)

Novo Nordisk Shanghai Pharmaceuticals Co., Ltd

Shanghai, China

Outcomes

Primary Outcomes

Health care professional's perceptions towards the role of systemic inflammation in the identification, treatment and management of patients with ASCVD and CKD

Multi-select from a defined list; Single-select from a defined list; Numerical; 7-point Likert scale for measurement of agreement to different statements from 1 "strongly disagree" to 7 "strongly agree"

Time frame: At the time of survey response (Day 1)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.